WDR7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.417600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.238000E-01
Normal-vs-Stage2
1.011410E-01
Normal-vs-Stage3
8.943700E-02
Normal-vs-Stage4
4.641600E-01
Stage1-vs-Stage2
4.179700E-02
Stage1-vs-Stage3
3.653900E-02
Stage1-vs-Stage4
5.529600E-01
Stage2-vs-Stage3
3.24307247723254E-12
Stage2-vs-Stage4
4.866200E-01
Stage3-vs-Stage4
1.149830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.409400E-01
Normal-vs-AfricanAmerican
8.221400E-01
Normal-vs-Asian
3.001900E-02
Caucasian-vs-AfricanAmerican
1.403580E-01
Caucasian-vs-Asian
4.044100E-02
AfricanAmerican-vs-Asian
9.312500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.170000E-01
Normal-vs-Female
6.453800E-01
Male-vs-Female
2.012600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.933000E-01
Normal-vs-Age(41-60Yrs)
6.172600E-01
Normal-vs-Age(61-80Yrs)
4.054800E-01
Normal-vs-Age(81-100Yrs)
8.074400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.992000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.345000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.486200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.043800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.819600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.617400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.378400E-03
Normal-vs-Daily Drinker
1.859930E-02
Normal-vs-Weekly Drinker
4.686200E-02
Normal-vs-Occasional Drinker
9.769400E-01
Normal-vs-Social Drinker
9.448600E-01
Non Drinker-vs-Daily Drinker
9.464200E-01
Non Drinker-vs-Weekly Drinker
7.348000E-01
Non Drinker-vs-Occasional Drinker
1.682780E-01
Non Drinker-vs-Social Drinker
1.259620E-01
Daily Drinker-vs-Weekly Drinker
8.009000E-01
Daily Drinker-vs-Occasional Drinker
1.750160E-01
Daily Drinker-vs-Social Drinker
1.338850E-01
Weekly Drinker-vs-Occasional Drinker
2.061400E-01
Weekly Drinker-vs-Social Drinker
1.645600E-01
Occasional Drinker-vs-Social Drinker
9.624200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.671600E-01
Normal-vs-Grade 2
2.002200E-01
Normal-vs-Grade 3
1.627800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.266100E-02
Grade 1-vs-Grade 3
5.669800E-02
Grade 1-vs-Grade 4
3.671600E-01
Grade 2-vs-Grade 3
6.852600E-01
Grade 2-vs-Grade 4
2.002200E-01
Grade 3-vs-Grade 4
1.627800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.273700E-02
Normal-vs-NonDiabetic
4.796200E-01
Diabetic-vs-NonDiabetic
3.112000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.797300E-03
Normal-vs-NoPancreatitis
4.564400E-01
Pancreatitis-vs-NoPancreatitis
1.113660E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.257600E-01
Normal-vs-N1
1.139850E-01
N0-vs-N1
1.547410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.291500E-02
Normal-vs-TP53-NonMutant
8.983600E-01
TP53-Mutant-vs-TP53-NonMutant
1.119190E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
